These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 4370925)

  • 21. [Serum factors that inhibit in vitro immunological reactions in malignant tumor development in experimental animals].
    Lomakin MS; Larin AS; Mamaeva TN; Levitina VL
    Vopr Onkol; 1977; 23(10):76-82. PubMed ID: 202095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of liver cancer.
    World Health Organ Tech Rep Ser; 1983; 691():1-30. PubMed ID: 6314682
    [No Abstract]   [Full Text] [Related]  

  • 23. Significance of serum factors modifying cellular immune responses to growing tumours.
    Baldwin RW; Price MR; Robins RA
    Br J Cancer Suppl; 1973 Aug; 1():37-47. PubMed ID: 4374231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens.
    Meltzer MS; Oppenheim JJ; Littman BH; Leonard EJ; Rapp HJ
    J Natl Cancer Inst; 1972 Sep; 49(3):727-34. PubMed ID: 4345967
    [No Abstract]   [Full Text] [Related]  

  • 25. [Active immunization: circulating antibodies in experimental hepatoma].
    Más M; Chordi A
    Rev Med Univ Navarra; 1975; 19(1):41-7. PubMed ID: 188089
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 27. Passive but not active CD8+ T cell-based immunotherapy interferes with liver tumor progression in a transgenic mouse model.
    Romieu R; Baratin M; Kayibanda M; Lacabanne V; Ziol M; Guillet JG; Viguier M
    J Immunol; 1998 Nov; 161(10):5133-7. PubMed ID: 9820481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antigenic structure of mouse liver cell plasma membranes. II. Antigen of bile capillaries of liver cells and cuticle of intestinal mucosa epithelium in mice].
    Khramkova NI; Beloshapkina TD
    Tsitologiia; 1973 Nov; 15(11):1421-6. PubMed ID: 4361020
    [No Abstract]   [Full Text] [Related]  

  • 29. Growth of transplanted rat tumors following administration of cell-free tumor antigens.
    Tracey RS; Wepsic HT; Alaimo J; Morris HP
    Cancer Res; 1978 May; 38(5):1208-12. PubMed ID: 205357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surface organ-- specific mouse liver antigens in hepatomas].
    Beloshapkina TD; Khramkova NI; Gel'shteĭn VI; Mendis K
    Tsitologiia; 1970 Sep; 12(9):1164-9. PubMed ID: 4324826
    [No Abstract]   [Full Text] [Related]  

  • 31. Dendritic cell-based immunotherapy for hepatocellular carcinoma.
    Onji M; Akbar F; Horiike N
    J Gastroenterol; 2001 Nov; 36(11):794-7. PubMed ID: 11757756
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study of phagocytic activity of macrophages and their RNA content in mice-tumor carriers and isologous intact mice].
    Aleksanian IuT; Manukian LA; Panosian SG; Karamanukian AK
    Zh Eksp Klin Med; 1974; 14(4):18-22. PubMed ID: 4370847
    [No Abstract]   [Full Text] [Related]  

  • 33. An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
    Chou CK; Hung JY; Liu JC; Chen CT; Hung MC
    Cancer Gene Ther; 2006 Aug; 13(8):746-52. PubMed ID: 16410824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma.
    Atarashi Y; Yasumura S; Nambu S; Yoshio Y; Murakami J; Takahara T; Higuchi K; Watanabe A; Miyata K; Kato M
    Hepatology; 1998 Jul; 28(1):57-67. PubMed ID: 9657097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cellular sensitization to fetal antigens during chemical carcinogenesis].
    Pasternak G; Schlott B; Gryschek G; von Broen B; Albrecht S; Reinhöfer J
    Biomed Biochim Acta; 1983; 42(6):777-84. PubMed ID: 6639648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy.
    Bartlett GL; Zbar B
    J Natl Cancer Inst; 1972 Jun; 48(6):1709-26. PubMed ID: 4341405
    [No Abstract]   [Full Text] [Related]  

  • 37. Ultrastructural studies of histiocyte-tumor cell interactions during tumor regression after intralesional injection of Mycobacterium bovis.
    Snodgrass MJ; Hanna MG
    Cancer Res; 1973 Apr; 33(4):701-16. PubMed ID: 4348772
    [No Abstract]   [Full Text] [Related]  

  • 38. Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications.
    Fatourou EM; Koskinas JS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1499-510. PubMed ID: 19828011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of lymphoid cells from hepatectomized mice on the growth of hepatoma 22a].
    Fel' VIa; Malygin AM
    Tsitologiia; 1974 May; 16(5):651-4. PubMed ID: 4366400
    [No Abstract]   [Full Text] [Related]  

  • 40. Suppression and immunotherapy of the guinea pig line-10 hepatocarcinoma mediated by nonviable Staphylococcus aureus.
    Minden P; McClatchy JK; Brunda MJ
    J Natl Cancer Inst; 1978 Aug; 61(2):535-8. PubMed ID: 210295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.